Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer

Adjuvant chemotherapy recommendations for ER+/HER2− early-stage breast cancers (eBC) involve integrating prognostic and predictive information which rely on physician judgment; this can lead to discordant recommendations. In this study we aim to evaluate whether Oncotype DX improves confidence and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Licata, Luca, Viale, Giulia, Giuliano, Mario, Curigliano, Giuseppe, Chavez-MacGregor, Mariana, Foldi, Julia, Oke, Oluchi, Collins, Joseph, Del Mastro, Lucia, Puglisi, Fabio, Montemurro, Filippo, Vernieri, Claudio, Gerratana, Lorenzo, Giordano, Sara, Rognone, Alessia, Sica, Lorenzo, Gentilini, Oreste Davide, Cascinu, Stefano, Pusztai, Lajos, Giordano, Antonio, Criscitiello, Carmen, Bianchini, Giampaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250312/
https://www.ncbi.nlm.nih.gov/pubmed/37291235
http://dx.doi.org/10.1038/s41523-023-00559-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250312/
https://www.ncbi.nlm.nih.gov/pubmed/37291235
http://dx.doi.org/10.1038/s41523-023-00559-6

Ejemplares similares